Join us for a virtual discussion and hear from institutional investors and managers about the impact of the SEC Private Fund Advisers proposal and other US regulatory dossiers.
Topics for discussion:
Head of External Partnerships, Alberta Investment Management Co. (AIMCo)
Managing Director, Head of Investment Operations, Howard Hughes Medical Institute
MD, Global Head of Government & Regulatory Policy, Citadel Advisors
Stephen Berger is a Managing Director and Global Head of Government & Regulatory Policy at Citadel. He leads the firm’s engagement on legislative and regulatory initiatives impacting the financial markets globally, including in the United States, Europe, and the Asia-Pacific region.
Mr. Berger has testified before the House Agriculture Committee on the impact of the G-20 clearing and trade execution requirements, presented before CFTC advisory committee meetings on issues including package transactions and position limits, participated in workshops at the New York Fed and Chicago Fed on CCP recovery and resolution, and spoken on panels at MFA, FIA, Eurofi and ASIFMA conferences on topics ranging from cross-border harmonization to US Treasury market structure modernization.
Mr. Berger is a member of the CFTC’s Market Risk Advisory Committee and the Federal Reserve Bank of Chicago’s Working Group on Financial Markets. He has served as Chair of the Managed Funds Association’s Derivatives and Swaps Committee and is an active participant in a number of MFA, AIMA, SIFMA AMG, FIA and ISDA committees.
Prior to joining Citadel, Mr. Berger was an Executive Director at UBS Investment Bank, where he led UBS’s US financial regulatory reform team.
Mr. Berger received a bachelor’s degree from Princeton University.
Executive Director, SBAI
Thomas Deinet was appointed Executive Director of the SBAI (previously known as the HFSB) in 2008. In 2007, Thomas joined the working group to project manage the development of practice standards proposed by 14 leading international alternative investment managers that led to the establishment of the SBAI.
Prior to joining the SBAI, he was a senior manager at Oliver Wyman, where he extensively worked with major financial institutions in Europe covering asset management as well as corporate and investment banking. Thomas also worked as an analyst in energy trading for a major commodities trading firm.
Thomas is a graduate of the University of Karlsruhe, Germany, with a major in industrial engineering and holds an MSc from Purdue University, USA. Thomas is a CFA charterholder.
Head of External Partnerships, Alberta Investment Management Co. (AIMCo)
Brandon Gill New leads AIMCo’s External Partnerships team, overseeing the Plan’s external Public Equity and Absolute Return investments. At AIMCo, Brandon oversees the strategy, success, and growth of the External Partnerships portfolio, builds and nurtures client and partner relations, and contributes to setting long-term strategic goals.
Prior to joining AIMCo, Brandon spent 5 years at OPTrust, most recently as the Managing Director & Head, Multi-Strategy Investments and Digital Assets. Previously, Brandon was a Director at BMO Capital Partners, a proprietary private debt and equity fund at Bank of Montreal. She also spent a decade at Ontario Teachers’ Pension Plan, serving as a Portfolio Manager in the Alternative Investments Division, managing a portfolio of global hedge funds and esoteric investment funds.
Brandon holds an MBA from London Business School and a BA in International Economics from Middlebury College in Vermont. She is also a CFA Charter holder. Brandon currently serves the Chair of the Investment Advisory Committee for The Junior League or Toronto’s Legacy Fund, and as a representative on the North American Advisory Committee of the Standards Board of Alternative Investments.
Managing Director, Head of Investment Operations, Howard Hughes Medical Institute
Glen is Managing Director and Head of Investment Operations of Howard Hughes Medical Institute (HHMI), a science philanthropy whose mission is to advance basic biomedical research and science education. HHMI’s endowment was valued at approximately $27 billion at the end of its last fiscal year. The investment portfolio is global and highly diversified across various asset classes. In addition to serving as a member of the senior investment team, Glen’s responsibilities include managing a 15-person team overseeing all aspects of fund operations, compliance, reporting, policy implementation, operational due diligence, technology, administration and other areas.
Glen previously served as HHMI’s Chief Investment Counsel. Prior to joining HHMI in 2005, Glen spent seven years as an attorney at Clifford Chance. During that time, he advised numerous U.S. and international fund sponsors and institutional investors. He also represented clients in M&A, capital markets and other financing transactions.
Glen earned his Juris Doctor, Master of Science and Bachelor of Arts degrees from Georgetown University in Washington, DC.